Physician profile
Sindu Pillai
NPI 1114087228
$1,397.80
in general payments reported to CMS, 2019-2025
17 companies · $328 in 2025
The $328 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $93.43 · 2021: $138 · 2022: $124 · 2023: $292 · 2024: $133 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $753.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $308.68 | 2019-2024 | |
| Cranial Technologies, INC | $237.50 | 2019-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $150.98 | 2020-2025 | Vaxneuvance, Gardasil 9, M-M-R II |
| Collegium Pharmaceutical, INC. | $129.56 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $116.27 | 2019 | |
| Sanofi Pasteur INC. | $81.17 | 2020-2023 | |
| Ironshore Pharmaceuticals INC. | $64.15 | 2019-2024 | |
| Ars Pharmaceuticals Operations, INC. | $54.27 | 2025 | Neffy |
| Mylan Pharmaceuticals INC. | $46.46 | 2019 | |
| Vertical Pharmaceuticals, LLC | $38.73 | 2019 | |
| Alk-Abello, INC | $30.37 | 2025 | Odactra, Ragwitek, Grastek |
| Kaleo, INC. | $29.80 | 2020 | |
| Supernus Pharmaceuticals, INC. | $24.38 | 2021 | |
| Verrica Pharmaceuticals INC. | $24.26 | 2025 | Ycanth |
| Sobi, INC | $23.72 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $23.66 | 2023 | Flumist Quadrivalent |
| Lnhc, INC | $13.84 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sindu Pillai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.